Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Accelerated Approval

<< Previous

Bullboard Posts

Next >>

Comment by DJDawgon Jun 30, 2023 2:02pm

255 Views

Post# 35522676

RE:RE:RE:Accelerated Approval

I think the price is stalled for a few reasons
- historically there have been PP's at 0.25 so I think many expect that a PP offering may be announced in which case, if the stock price is above 0.25, certain investors may just sell on the open market to get in on the PP at 0.25 (plus get a warrant usually)
- A while ago some large asks got planted on the 2nd order and just sit there. Right now there is an ask of 0.3 for 113000. Those just put a damper on things and prevent any price jumps.
- no clarity on finances at moment
- not enough PR to bring in new buyers. All of us are maxed out (I am) medium or longholders.

IMO

<< Previous

Bullboard Posts

Next >>

This AI stock is disrupting the event tickets monopoly